The Inspire Sleep Apnea Implant is a medical device that’s implanted into the body for the treatment of snoring and obstructive anti snoring (OSA) syndrome.
Obstructive ANTI SNORING Syndrome
Obstructive anti snoring syndrome is a disease due to relapsing episodes of sleep apnea. It is a condition where breathing stops for more than 10 seconds, during which oxygen saturation in the blood is reduced by more than 4%.
OSA syndrome occurs during sleep, when the muscles of upper airways relax, evoking the obstruction of the respiratory tract. This leads to deterioration of blood oxygenation and provokes short unconscious wake-up episodes through the entire night. An unhealthy pattern of sleep places stress on the body, causing increased blood circulation pressure and development of severe diseases. The diseases due to OSA could be physical, such as for example hypertension, myocardium infarction and stroke. They could also be mental, including depression, chronic fatigue syndrome, loss of memory and concentration.
Before any treatment, a sleep study or a polysomnography is necessary. The polysomnography calculates the apnea index, that is the frequency of apnea episodes during one hour of sleep and determines the severity of the condition. The apnea index is known as significant if there are a lot more than 20 apnea episodes each hour, whatever the presence or lack of clinical symptoms.
The gold standard of treatment for OSA syndrome is CPAP-therapy. However, CPAP therapy isn’t for everyone as many people think it is uncomfortable to sleep with the mask on the face and the device itself could be loud, especially since it commonly sits near the head. Only 25% of patients can use CPAP-therapy for an extended period of time.
Therefore, recently Inspire Medical Systems Inc. has come up with a very effective solution with the Inspire ANTI SNORING Implant.
How The Inspire ANTI SNORING Implant Works
The Inspire ANTI SNORING Implant is really a battery operated device that promotes electrostimulation of the sublingual nerve. The battery life is approximately a decade.
The main unit of the device is placed under the skin, on the front right side of the chest also it monitors the phase of breathing. The other electrode is implanted for stimulation of the sublingual nerve, which creates muscle tension. This opens top of the airways and allows the tongue to stand out, and helps maintain the airways open during sleep.
As well as the two electrodes, this device also contains a handy small remote switch, that actually turns on these devices before sleep and switches it off once awake. This disables the electrodes from disturbing the processes of communication and eating through the active phase of the day, when a person needs physiological narrowing of the larynx and tongue movements for these processes.
The individual may feel light involuntary contractions of the larynx, or tongue movements during initial usage of these devices. ufabet These movements do not cause pain, instead only a minor discomfort. These unpleasant effects disappear after the first few uses of these devices.
Generally, the implant should be checked 1 or 2 2 times per year. However, depending on the situation, an Inspire therapy-trained doctor may consult patients pretty much often.
The Inspire Sleep Apnea Implant is only suitable for:
Patients who are a lot more than 22 years old.
Patients who’ve been identified as having moderate or severe obstructive anti snoring syndrome.
Patients having an apnea index in the range of 20 to 65.
Patients who are not comfortable with using CPAP therapy or did not work.
Patients with a body mass index of significantly less than 32.
Body mass index (BMI) = weight (kg) / height^2 (m2).
A person with a weight of 80 kg and a height of 170 cm has
BMI = 80kg / (1.7m ^ 2) = 80 / 2.89 = 27.68 kg/ m2
The Inspire Sleep Apnea Implant may potentially replace CPAP therapy as ‘the gold standard’ of treatment for obstructive sleep apnea syndrome. A report by Dr. Ryan J. et al. has shown that after implantation of the Inspire Sleep Apnea Implant, snoring is greatly decreased. A share of “no” or “soft” snoring changed from 22% at beginning of the treatment to 88% at 12 months and 91% at 24 months after the treatment. Also, the apnea index was reduced from 31 to 14. 82% of the patients in the study reported a nightly usage of this therapy for five years. Therefore, it is evident that method is impressive and simple to use!